Andrea Gruneir, PhD

Lithium is an important mood disorder treatment, but the renal risks in older adults are unclear. This population-based cohort study looked at risk of renal decline with lithium vs...

Lithium treatment, while effective for mood disorders, necessitates frequent drug level and renal monitoring in older patients to prevent serious adverse events. Read this article to see if older...

Could mood-stabilizing medications be increasing patients' risk of developing kidney disease? This large, nested case-control study looks at the degree of risk associated with lithium and valproate treatment in...

Almost 50% of women with schizophrenia become pregnant, but there may be concerns about their stability during pregnancy and after delivery. Fortunately, the authors of this study offer encouraging...